Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
Open Access
- 5 December 2018
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 20 (1) , 1-11
Abstract
Increasing evidence indicates a pathogenic role of deregulated autophagy in rheumatoid arthritis (RA). We examined the relationship between autophagy and inflammatory parameters in patients with RA receiving biologic therapy. In 72 patients with RA and 20 healthy control subjects (HC), autophagosome levels were determined by the mean fluorescence intensity (MFI) of autophagosomotropic dye incorporated into circulating immune cells, and p62 expression levels in immune cells were measured by flow cytometry. We used immunoblotting to examine protein expression of LC3-II and p62 in peripheral blood mononuclear cells. Patients with RA had significantly higher levels of autophagosome reflected by MFI of Cyto-ID in circulating lymphocytes, monocytes, and granulocytes (median values, 3.6, 11.6, and 64.8, respectively) compared with HC (1.9, 6.0, and 35.8; respectively) (all p < 0.001). p62 MFI levels in lymphocytes and granulocytes from patients with RA (17.1 and 8.6, respectively) were significantly lower than those in the corresponding cells from HC (20.2, p < 0.05; and 13.1, p < 0.001, respectively). Significantly higher levels of LC3-II protein expression in contrast to lower p62 protein levels were observed in patients with RA than in HC. The autophagosome levels in immune cells were significantly correlated with inflammatory parameters in patients with RA, and they were significantly decreased with disease remission after treatment with tumor necrosis factor-α inhibitors or interleukin-6 receptor inhibitor. Elevated autophagy with significant correlation to inflammation suggests the involvement of autophagy in RA pathogenesis. The effectiveness of biologic therapy might be partly related to the downregulation of autophagy expression.Keywords
Funding Information
- National Science Council (MOST 104-2314-B-075A-005-MY3)
This publication has 48 references indexed in Scilit:
- Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritisInternational Immunopharmacology, 2018
- Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritisOncotarget, 2016
- Autophagy and mitochondrial dysfunction in adjuvant-arthritis rats treatment with resveratrolScientific Reports, 2016
- Recent insights into the role of autophagy in the pathogenesis of rheumatoid arthritisRheumatology, 2015
- Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targetsRheumatology, 2014
- Autophagy regulates TNFα-mediated joint destruction in experimental arthritisAnnals of the Rheumatic Diseases, 2013
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Autophagy: process and functionGenes & Development, 2007
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995